Emerging therapeutic alternatives for snakebite envenoming
Enregistré dans:
| Auteur: | |
|---|---|
| Format: | contribución de congreso |
| Date de publication: | 2019 |
| Description: | The primary treatment for snakebite envenoming remains the administration of animal-derived antivenoms. While highly effective against systemic manifestations, antivenoms present drawbacks, including the need for trained healthcare staff, limited specificity (being restricted to the venoms used in immunization), and the risk of adverse reactions. |
| Pays: | Kérwá |
| Institution: | Universidad de Costa Rica |
| Repositorio: | Kérwá |
| Langue: | Inglés |
| OAI Identifier: | oai:kerwa.ucr.ac.cr:10669/104658 |
| Accès en ligne: | https://hdl.handle.net/10669/104658 https://doi.org/10.1016/j.toxicon.2019.06.044 |
| Mots-clés: | Snakebite envenoming Antivenoms Recombinant antibodies Toxin inhibitors Phospholipases A2 Metalloproteinases Nanoparticles |